iLAVA of Arizona owns 100% of a cultivation and processing license and is now requesting proposals for a financed operator with cultivation experience to enter one of America’s top cannabis markets. Our ideal partner must be focused on quality control, compliance, and has experience designing and building out cannabis cultivation operations. The Arizona medical marijuana program and upcoming adult use initiative do not limit cultivation canopy size or limit plant count. Arizona’s population is over 7.2 million as of 2019.



<!–

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});
–>

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});

Over 190,000 lbs. of medical marijuana is sold per year in the Arizona cannabis market. In May 2020, cannabis sales in Arizona’s medical dispensaries reached $93 million, growing seven percent from April. There are currently over 245,000 registered medical marijuana patients in Arizona and patient cards are valid for 2 years.

The iLAVA management team opened The Downtown Dispensary in 2013 which has won Best of Tucson® in 2015, 2016, 2017, and 2019. The iLAVA team currently operates 2 dispensaries and an industrial medical marijuana cultivation/production facility with 120+ employees in Tucson. iLAVA products are also distributed in 80+ dispensaries statewide including the bestselling topical in Arizona, iLAVA Touch, in addition to our vape cartridges & extracts. Arizona currently has 126 operating dispensaries statewide.

The iLAVA distribution network and the product expertise of our retail staff will be available to our potential partners. This opportunity includes cultivation and can include marijuana product manufacturing & distribution depending on negotiated deal terms.

Due to Arizona’s medical marijuana laws and our internal practices, any qualified individuals must be able to pass a criminal background check and provide proof of funding upon request.

This opportunity is being listed by the iLAVA management  team (Moe Asnani & Chip Boyden) and not by a broker or third party.

Interested parties can email their proposals to enter the Arizona market at [email protected].

This is a paid post. Contact [email protected] for more information.

Pure CBD Hemp Oil

  • Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

  • Clinically proven therapeutic effects.

  • Relieves anxiety and stress

  • Eliminates chronic pain and aches

  • Regulates mood and sleep patterns

  • Enhances focus and clarity

pure cannabis oil

additional information, George Scorsis

Originally posted on via Cannabis Industry News

Plus Products Launches Highest Concentrated Cannabis Gummy in California with New HI-CUBES Brand – New Cannabis Ventures

SAN MATEO, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded products company in the U.S., today announced the launch of its new HI-CUBES brand into the California adult-use market.

Highlights

  • Most concentrated gummy product (THC by volume) available in the California market.1
  • 100% whole plant, full-spectrum oil delivers cannabinoids, flavonoids and aromatic terpenes for a more dynamic high.
  • Great tasting and guilt-free: only 5 calories and less than 1g of sugar per cube.
  • New line-up will initially include two high THC gummy products specifically formulated for cannabis users looking for a stronger psychoactive effect.

HI-CUBES is the third edibles brand launched by PLUS, well known for its core brand of high-quality and precisely dosed gummies and mints.

With 10mg of THC packed into each 5 calorie serving, HI-CUBES are the most concentrated gummy products available within the California market.1 Manufactured with 100% whole-plant, full-spectrum oil, the product delivers an array of cannabinoids, flavonoids and aromatic terpenes to create a powerful effect for consumers looking for an intense cannabis experience. This new line offers consumers the same great-tasting and guilt-free product experience as PLUS gummies, with less than 1g of sugar per cube.

Following the launch of our PLUS CBDRelief brand this past February, we are excited to further expand our portfolio to ensure that consumers looking for all different types of experiences can turn to our brands for their cannabis needs.

Jake Heimark, Co-founder and CEO.

The new brand, HI-CUBES, initially includes two flavors – Indica Plum and Sativa Strawberry – each with 10mg of THC per gummy, and 100mg of THC per package. These products are currently available in over 40 licensed retailers across the state of California.

(1) According to internal market research.

Availability

California THC: PLUS cannabis-infused edibles are currently available in over 360 licensed retailers across the state of California. PLUS CBDRelief cannabis-infused gummies are currently available in over 240 licensed retailers across the state of California. HI-CUBES cannabis-infused gummies are expected to continue rolling out to licensed retailers across the state in the coming weeks.

Nevada THC: PLUS cannabis-infused gummies are currently available in licensed retailers throughout Las Vegas.

National Hemp CBD: PLUS 100% hemp CBD-infused gummies are available for purchase in 43 states across the country at plusproducts.com.

About PLUS

PLUS is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA.

Original Press Release

Originally posted on Plus Products Launches Highest Concentrated Cannabis Gummy in California with New HI-CUBES Brand – New Cannabis Ventures via Cannabis Industry News

(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the cannabis industry. Naomi Granger, CPA, MBA, is the co-founder of Dope CFO.)

 Cannabis companies should expect an uptick in IRS audits.

A recent report by the Treasury Inspector General for Tax Administration puts a target on marijuana.

Companies that have failed to pay their full federal tax obligations or neglect to maintain clean, well-organized books will be in for a rude awakening if the taxman comes visiting.

If the IRS knocks on your door, preparation is key.

Start getting your house in order with these seven tactics:



<!–

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});
–>

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});

1. Don’t bury your head in the sand.

The books and records are always the responsibility of the business owner. CEOs cannot bury their heads in the sand.

It’s the owner who will be faced with litigation and held responsible for any back taxes or penalties and possibly even jail time if statements are considered criminal.

Have a high-level understanding of what’s required of you from an accounting and tax standpoint and have checks and balances in place to ensure whomever you are hiring is performing adequately.

2. Are these expenses ordinary and necessary?

It’s tempting to claim deductions on your business expenses, but make sure those purchases truly meet the standard of being ordinary and necessary.

For example, when making large purchases, such as a company car, a new piece of equipment or even a new piece of software, you must be able to make a business case for such expenses.

A company car intended to improve the image of a dispensary is not “necessary” and likely wouldn’t pass as a marketing expense.

However, if your business provides transportation and delivery services and a company car is needed, then you’ve passed the “necessary” test.

Then there’s the “ordinary” test. A delivery business wouldn’t need to purchase a Bugatti to perform those services. A more reasonable, reliable and fuel-efficient vehicle would pass the test over a high-end luxury brand.

3. Substance over form.

The IRS looks at the economic substance of a transaction over the legal form.

For instance, if you were advised to set up multiple legal entities to get around Section 280E (including federally legal businesses such as a management company, a payroll firm or a leasing company) and these entities exist solely to support your cannabis business, the IRS will consider this as one cannabis enterprise and the entire structure will be subject to 280E, regardless of the legal form.

4. Receipts – or it didn’t happen.

Work with your accountant to set up an easy receipt- and expense-management system.

Use systems such as Expensify, Hubdoc, and Concur with mobile apps so that you can take pictures of your receipts immediately as you collect them.

In the event of an audit, you’re going to want to be able to substantiate at a minimum 80% of each profit-and-loss (P&L) line item.

Not having proper support could open up your business to the risk of the IRS pulling an additional year to audit due to your books being incorrect during the year under audit.

Bank statements and credit card statements alone are not enough.

You will need invoices and receipts for purchases.

Invoices help the auditors understand what was purchased and when the purchase was made, and receipts help auditors confirm that the invoice was actually paid and there are no further liabilities associated with that purchase.

With only a bank statement, we’re unable to determine if the expense is properly categorized on the P&L.

Additionally, accrual accounting requires expenses to be booked as incurred, and since payment terms vary from vendor to vendor, a bank statement does not give enough information about when an expense was incurred.

Another thing to look out for when using bank statements: Be careful with deposits and transfers. All items that hit the account are considered income. Proper documentation and the ability to substantiate business income is a must.

5. Document to remember.

Not only do you need support, but you must also document the accounting treatment. The cannabis industry is highly regulated, and the regulations are constantly changing.

A properly trained accountant understands how to document the accounting treatment for these purchases based on the facts and circumstances at the time.

The Californians Helping to Alleviate Medical Problems (CHAMP) tax court case in 2007 is an example of great accounting, while the Alterman case, which was decided in 2018, is an example of both poor accounting and poor recordkeeping.

IRS audits typically come three to four years after the fact.

It’s very difficult to go back four years and remember why a particular expense was capitalized to inventory, when current facts and circumstances would not allow the capitalization of this expense.

6. Time is of the essence.

When working with the IRS, you will need to be cognizant of, and adhere to, the deadlines set during the audit.

You will need to respond, submit documentation, argue, reply or contest within these deadlines, as missing these deadlines might result in you waiving your rights to appeal.

7. Don’t go it alone.

Ensure you have a good attorney and a tax CPA in place to help you through the process. Do not try to work through the audit with just yourself and a bookkeeper.

The goal is to provide the IRS with all the information requested and to come to an agreement without taking this to litigation.

Litigation can take years and can be extremely expensive, so do things properly up front to save time and money in the long run.

Naomi Granger is cofounder of Dope CFO. She can be reached at [email protected]

The previous installment of this series is available here.

To be considered for publication as a guest columnist, please submit your request to [email protected] with the subject line “Guest Column.”

Pure Cannabis Hemp Oil

  • Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

  • Clinically proven therapeutic effects.

  • Relieves anxiety and stress

  • Eliminates chronic pain and aches

  • Regulates mood and sleep patterns

  • Enhances focus and clarity

pure cannabis oil

more info, George Scorsis website

Originally posted on via Cannabis Industry News

Former Deputy Assistant AG in the Antitrust Division of the DOJ Gives Insider View On Cannabis Antitrust

Here’s the meat of the piece but we very much advise all serious readers to take a closer look at this article more than once.  There are more big end of town M&A’s to come in the next 12 months and it looks like there are some battles to be fought.

Here, for example, is a core topic that will need to be considered, amogst may others.

Once cleared to the DOJ, Delrahim faced a legal conundrum that was a matter of first impression in the history of the Department of Justice.  As he explained in his letter, “the Division was forced to consider whether the antitrust laws could or should be applied to protect and promote lower prices and increased output of a substance that is facially illegal under federal law.” 

Author:Roger Alford
Roger P. Alford joined the Notre Dame Law faculty in January 2012. Alford teaches and writes in a wide range of subject-matter areas, including international trade, international arbitration, international antitrust, and comparative law.In addition to publishing widely in leading law reviews and journals, Alford is the general editor of Kluwer Arbitration Blog and on the Executive Committee of the Institute for Transnational Arbitration.

He writes for Just Security

Before addressing the specific question of how the Antitrust Division investigated the proposed mergers in question, it is useful to provide some historical context of how the Department of Justice has viewed the marijuana industry.  This history belies the allegation that federal enforcement policy against the sale and distribution of marijuana is based on the personal animus of particular DOJ officials.

Given the changing public attitudes about marijuana use, it may be difficult for many to appreciate the federal government’s official positions on the distribution and sale of marijuana.  As states increasingly moved toward the legalization of marijuana use, the Department of Justice has clarified its guidance on federal investigations and prosecutions.

In October 2009, the Obama Administration reiterated that “marijuana is a dangerous drug, and the illegal distribution and sale of marijuana is a serious crime.” The Obama DOJ announced that it is “committed to the enforcement of the Controlled Substances Act in all States,” particularly given that “marijuana distribution in the United States remains the single largest source of revenue for the Mexican cartels.”  Among the enforcement priorities the Obama DOJ announced was the “prosecution of commercial enterprises that unlawfully market and sell marijuana for profit.”

In June 2011 the Obama Administration provided additional guidance in response to states authorizing “multiple, large-scale, privately-operated industrial marijuana cultivation centers” with “revenue projections of millions of dollars based on the planned cultivation of tens of thousands of cannabis plants.”  The Obama DOJ warned that “persons who are in the business of cultivating, selling or distributing marijuana, and those who knowingly facilitate such activities, are in violation of the Controlled Substances Act, regardless of state law.” The Obama DOJ also warned “[t]hose who engage in transactions involving the proceeds of such activity may also be in violation of federal money laundering statutes and other federal financial laws.”

In August 2013 the Obama Administration provided still more guidance, stating that it will rely on state and local enforcement to address marijuana activities that do not implicate certain federal policies.  However, it reiterated that “state or local laws” do not provide a “legal defense to a violation of federal law” and “evidence that particular conduct threatens federal priorities will subject that person or entity to federal enforcement action, based on the circumstances.”  The Obama DOJ emphasized that “a marijuana operation’s large scale or for-profit nature may be a relevant consideration for assessing the extent to which it undermines a particular federal enforcement priority,” including priorities such as “preventing revenue from the sale of marijuana from going to criminal enterprises, gangs, and cartels,” and “preventing the diversion of marijuana from states where it is legal under state law in some form to other states.”

Finally, in January 2018, Attorney General Jeff Sessions announced that “[g]iven the Department’s well-established general principles, previous nationwide guidance specific to marijuana enforcement is unnecessary and is rescinded, effectively immediately.”  This had the effect of returning “local control to federal prosecutors who know where and how to deploy Justice Department resources most effectively.”

Thus, far from “personal dislike or animus” toward the industry, these pronouncements provide useful context on the federal government’s official positions on the sale and distribution of marijuana in the United States.  They also provide crucial insight on how the federal government might respond to efforts by marijuana companies to merge in order to more effectively sell and distribute marijuana in potential violation of federal law and federal priorities.

Read full article

Regarding Those Marijuana Mergers: A Response to Accusers Who Question the DOJ

Pure CBD Hemp Oil

  • Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

  • Clinically proven therapeutic effects.

  • Relieves anxiety and stress

  • Eliminates chronic pain and aches

  • Regulates mood and sleep patterns

  • Enhances focus and clarity

pure cannabis oil

George Scorsis

Originally posted on Former Deputy Assistant AG in the Antitrust Division of the DOJ Gives Insider View On Cannabis Antitrust via Cannabis Industry News

One of the cannabis industry’s only self-regulatory standards organizations is creating social equity recommendations for state rulemakers.

The goal of the National Association of Cannabis Businesses, based in Washington DC, is to get state marijuana regulators to change their ways.

Regulators have shown a tendency to want to start from scratch when developing rules for new cannabis programs and fail to consult other states’ existing frameworks.



<!–

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});
–>

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});

According to a news release, the NACB’s recommendations will address:

  • Criteria for social equity licensee candidates.
  • Support and services for qualified candidates.
  • Funding to disproportionately impacted communities.
  • Social justice reform.

“The objective is to assist all regulated cannabis states to move forward with programs to improve social and economic welfare at the local level,” Gina Kranwinkel, president and CEO of the association, said in a statement.

Kranwinkel said states can give licensing preferences and low-interest loans to create business ownership opportunities and jobs in disadvantaged communities.

For a sampling of organizations and efforts that support, foster and enhance social equity in the cannabis industry as well as opportunities for minorities, overall diversity and racial justice, click here. 

Pure CBD Hemp Oil

  • Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

  • Clinically proven therapeutic effects.

  • Relieves anxiety and stress

  • Eliminates chronic pain and aches

  • Regulates mood and sleep patterns

  • Enhances focus and clarity

pure cannabis oil

addiitional information, george scorsis

Originally posted on via Cannabis Industry News

Colorado, Illinois and Oregon have all maintained record-breaking sales numbers in recent months despite the coronavirus and the recession.



<!–

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});
–>

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});

In Colorado, marijuana shops sold more than $192 million in May, according to Denver alt-weekly Westword. That’s up from $148 million the month prior.

In Illinois, the state’s cannabis stores sold $47.6 million worth of marijuana in June, another record for the nascent recreational cannabis market, according to the Daily Herald of Arlington Heights. That was up from a high of $44 million in May.

In Oregon, marijuana sales totals hit $103 million in May, topping the $100 million mark for the first time, the Portland Business Journal reported.

Then the state set a record in June, reaching just over $100 million.

Pure CBD Hemp Oil

  • Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

  • Clinically proven therapeutic effects.

  • Relieves anxiety and stress

  • Eliminates chronic pain and aches

  • Regulates mood and sleep patterns

  • Enhances focus and clarity

pure cannabis oil

George Scorsis Liberty Health Sciences

Originally posted on via Cannabis Industry News

Canopy Growth Corp. laid off another 30 employees as part of its corporate restructuring, the company confirmed to Marijuana Business Daily.

The job losses at Canopy’s Smiths Falls, Ontario, headquarters were first reported by local news website InsideOttawaValley.com.



<!–

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});
–>

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});

The layoffs, which occurred July 8, affected operations staff members and were the result of Canopy Growth’s “ongoing strategic review of the business,” Jordan Sinclair, the company’s vice president of communications, said in a statement.

“This decision was made as we continue to adjust the business to match market demands,” Sinclair added.

The layoffs are the latest of many jobs shed by Canopy this year.

The Ontario-based company closed two major greenhouses in British Columbia in March, resulting in about 500 job losses.

In mid-April, Canopy eliminated 85 positions as it pulled back from cultivation in Africa, Colombia and the United States and closed a facility in Saskatchewan, Canada.

Another 200 Canopy employees were terminated in Canada, the United Kingdom and the U.S. in late April.

Canopy reported a significant fourth-quarter loss in late May and announced it was transitioning to focus on Canada, the United States and Germany.

Other major Canadian cannabis producers to lay off staff in 2020 include Aurora Cannabis and Organigram.

Pure Cannabis Hemp Oil

  • Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

  • Clinically proven therapeutic effects.

  • Relieves anxiety and stress

  • Eliminates chronic pain and aches

  • Regulates mood and sleep patterns

  • Enhances focus and clarity

pure cannabis oil

additional info, George Scorsis

Originally posted on via Cannabis Industry News

Cannabis regulators in Canada’s Northwest Territories (NWT) reduced prices of legal marijuana products by 10% in an effort to eliminate illicit marijuana sales.

The price cuts, which took effect July 2, apply to all cannabis products sold by the Northwest Territories Liquor and Cannabis Commission (NTLCC), the NWT government said.



<!–

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});
–>

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});

“With close to two years of legal sales, NTLCC has a better understanding of the operating costs associated with the distribution and sale of cannabis and is confident that it can reduce the price of these products while continuing to maintain a safe and secure retail regime,” the agency noted.

NTLCC sells regulated cannabis out of five liquor stores across the vast northern territory, which is home to roughly 45,000 people. It also operates an online cannabis store.

“We will continue to assess the operations of the Northwest Territories Liquor and Cannabis Commission to find more ways to curb the illegal sale of cannabis in the Northwest Territories in a socially responsible manner,” NWT Finance Minister Caroline Wawzonek said in a statement.

The price of legal cannabis has come under scrutiny since the country legalized adult-use marijuana in October 2018.

In the past year, a number of Canada’s licensed cannabis producers have introduced discount brands in an attempt to capture consumer demand for more affordable products.

Some government-operated cannabis retailers have joined in on the price-cutting trend.

For example, New Brunswick’s Cannabis NB retailer recently renegotiated prices with suppliers to provide savings for customers.

Pure CBD Hemp Oil

  • Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

  • Clinically proven therapeutic effects.

  • Relieves anxiety and stress

  • Eliminates chronic pain and aches

  • Regulates mood and sleep patterns

  • Enhances focus and clarity

pure cannabis oil

George Scorsis Aphria

Originally posted on via Cannabis Industry News

Toronto-headquartered Ramm Pharma, a company with medical cannabis manufacturing operations in Uruguay, said the Peruvian Ministry of Health approved its Epifractán 5% CBD product “for sale in pharmacies throughout the country for various indications as prescribed by a medical doctor.”

The news underscores the limited but increasing Latin American intraregional medical cannabis trade, independent from North American cannabis production.

Ramm Pharma “entered into an agreement with CannFarm Peru S.A.C. to distribute its products throughout Peru,” the company said in a news release.

The only other registered “cannabis-derived natural health product” – a category created by Peruvian regulations – belongs to Canada-based Canopy Growth and also has CBD as the active ingredient.



<!–

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});
–>

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});

Niklaus Schwenker, director of communications and strategy for Canopy Growth Latin America, told Marijuana Business Daily that Peru “has one of the most advanced regulations for cannabis in Latin America and is a priority for the Canopy Growth in the region.”

With product approval already in place, the company expects to “serve Peruvian patients in the near term while continuing its physician-education activities through the Spectrum Academy,” Schwenker said.

Companies with registered products must obtain the necessary import permits to be able to receive the shipments and distribute to pharmacies around the country, Andres Vazquez Vargas, CEO of CannFarm Peru, told MJBizDaily.

“After obtaining the import permit, we expect to receive the first shipment from Uruguay and start distributing to patients in Peru in the next weeks,” Vazquez said.

The product to be imported by CannFarm is registered in Uruguay by the correspondent Ministry of Health and has been available in pharmacies under prescription since 2018.

Ramm Pharma, the producer, has a Good Manufacturing Practice certification from the Uruguayan Ministry of Health.

The company currently exports from Uruguay to neighboring countries, such as Brazil and Argentina, under “compassionate use” programs, which generally means the products must be shipped case-by-case to specific authorized patients.

As of July 10, the public database of the Peruvian health authority showed 17 product registrations were submitted by six companies and were pending approval.

This is in addition to Sativex, manufactured by GW Pharmaceuticals in the United Kingdom, which was approved as a cannabis-derived pharmaceutical but is still not being commercialized, according to local sources.

As of early July, only a CBD product was available for patients in Peru, and it is sold by the Peruvian General Directorate of Medicines, Supplies and Drugs (DIGEMID) in only one pharmacy in the country. That pharmacy is run by the health agency.

That product was bought by the country health authority through two different supply tenders.

Alfredo Pascual can be reached at [email protected]

Pure CBD Hemp Oil

  • Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

  • Clinically proven therapeutic effects.

  • Relieves anxiety and stress

  • Eliminates chronic pain and aches

  • Regulates mood and sleep patterns

  • Enhances focus and clarity

pure cannabis oil

George Scorsis

Originally posted on via Cannabis Industry News

Virginia Medical Cannabis Sales Set to Commence Within Two Months – New Cannabis Ventures

Virginia’s Board of Pharmacy awarded five cannabis processing licenses in late 2018, and three of the recipients are expected to begin dispensing cannabis products to patients within the next two months. The program remains rather narrow at the onset, even after several big improvements, but, like many other states, it should expand in the years ahead. In this review, we discuss the history and rules of the program, review the licensed operators and assess the likelihood of growth.

History and Program Rules

In early 2016, the Virginia, which has a population of 8.5 million, legalized CBD and THCA for the treatment of intractable epilepsy when former Governor Terry McAulliffe signed HB 1445/SB 1235 into law and then passed additional legislation signed by Governor Ralph Northam in 2018, HB 1251, expanding it to any medical condition. The Board of Pharmacy fielded 51 applications in 2018 after dividing the state into five regions, awarding one pharmaceutical processing license within each region, which is calls Health Service Areas (HSAs). Each processor will be able to open up to five additional dispensaries in 2021. The initial winners included Columbia Care (CSE: CCHW) (NEO: CCHW) (OTC: CCHWF), Dalitso, Dharma Pharmaceuticals, Green Leaf Medical and PharmaCann.

The state allowed practitioners to begin issuing written certifications on July 1, 2019 when it passed SB 1557. Practitioners include not only doctors or osteopaths but also physician assistants and nurse practitioners.

The process for becoming a patient is simple, with a $50 initial fee and a $50 annual renewal. The state permits CBD oil and THC-A oil, which limits THC to no more than 5%. Dosing is limited to 10mg of THC. The product set was limited initially but now, following the passage of SB 1557, includes a wide variety, including edibles, patches and vape pens.

According to the Board of Pharmacy, 3 operators that are already cultivating will be ready to begin dispensing by late summer, while a fourth will complete construction in July. Virginia permits wholesale activities between its processors.

Review of the Operators

Pharmacann, which received the processing license for HSA I, an area that includes Charlottesville, transferred it to MedMen (CSE: MMEN) (OTC: MMNFF). In June, the Board of Pharmacy rescinded the approval due to MedMen not developing its operations in a timely manner. It plans to open a Request for Application later this year.

HSA II in Northern Virgina (the counties of Arlington, Fairfax and Prince William) will be served by Jushi Holdings (CSE: JUSH) (OTC: JUSHF), which acquired 62% of Dalitso for $16 Million in cash and stock. The company operates the Beyond/Hello brand of dispensaries and will open its first in Manassas. CEO Jim Cacioppo considers the state one of Jushi’s top three markets. In a recent New Cannabis interview, he predicted that his company could reach at least 25% share across the state.

Locally owned Dharma Pharmaceuticals, which built its processing center in a vacant portion of the Bristol Mall, is serving HSA III in Southwestern Virginia.

Green Leaf Medical has built an 82,000 sq ft facility in Manchester, adjacent to the capital city of Richmond, where it will serve patients in 27 counties that comprise HSA IV. Based in Maryland, with operations in Pennsylvania and Ohio as well, the company expects to begin serving patients in October. The privately held MSO was able to borrow $10 million from Chicago Atlantic Group in April to fund the Virginia build out. New Cannabis Ventures interviewed CEO Phil Goldberg earlier this year, and he suggested that Virginia’s contribution could help the company boost revenue from a projected $90 million in 2020 to $160 million next year.

Columbia Care will serve HSA V, which includes several of the state’s largest cities, including Virginia Beach, Norfolk, Chesapeake, Newport News, Hampton and Portsmouth. The company has built a 65,000 sq. ft. facility in Portsmouth. CEO Nicholas Vita discussed the operations in a recent New Cannabis Ventures interview.

Looking Ahead

Many states start low and go slow, as Virginia has done with its limited program in its early days. No longer restricting medical conditions is a major positive, and it seems likely the state will further expand the program over time, as has been the case in other states. The recent addition of a broad array of form factors should boost strong initial uptake, and hopefully the state will add flower and remove the THC caps over time. The state could also legalize for adult-use within two years. In March, the House and Senate approved legislation that created the Joint Legislative Audit and Review Commission that will report later this year on recommendations for “how Virginia should go about legalizing and regulating the growth, sale, and possession of marijuana by July 1, 2022, and address the impacts of marijuana prohibition.”

Originally posted on Virginia Medical Cannabis Sales Set to Commence Within Two Months – New Cannabis Ventures via Cannabis Industry News

Design a site like this with WordPress.com
Get started